$53.88 0.01 (+0.02%)
11/25/2009 4:02 PM

Covance, Inc. (CVD)

CAPS Rating: 4 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Results 1 - 20 of 45 1 2 3 Next »

Recs

0
Member Avatar BLAYNE100 (87.28) Submitted: 11/16/2009 8:46:42 PM : Outperform Start Price: $53.76 CVD Score: -0.19

Strong Sector for 2010

Recs

0
Member Avatar mrmok (73.20) Submitted: 11/16/2009 1:53:32 AM : Outperform Start Price: $53.70 CVD Score: -0.57

FC

Recs

0
Member Avatar wooderino (89.91) Submitted: 10/27/2009 12:35:38 PM : Outperform Start Price: $54.69 CVD Score: -5.74

Showed up on a screen for solid 5 year growth with low debt, cash on hand and still at attractive P/E ratios.

Recs

0
Member Avatar NRT104 (< 20) Submitted: 8/9/2009 9:22:24 AM : Outperform Start Price: $54.72 CVD Score: -12.62

drus will go up

Recs

0
Member Avatar TMFHelical (98.19) Submitted: 7/23/2009 10:29:43 AM : Outperform Start Price: $47.70 CVD Score: -2.04

Blanket pick on the CRO market under the assumption that it will return to growth in 2010. This just seems like the right time to make this call (we'll see).

TMFHelical

Recs

0
Member Avatar Turtlebale (27.38) Submitted: 5/18/2009 2:54:54 PM : Outperform Start Price: $39.61 CVD Score: +12.03

best name in CRO industry; services valued highly by their clients.

Recs

0
Member Avatar hondo928 (99.75) Submitted: 3/10/2009 4:18:50 PM : Outperform Start Price: $44.75 CVD Score: -9.53

I have bull picks on all of these companies ICON, PRXL etc.

Recs

0
Member Avatar TMFBiologyFool (92.02) Submitted: 2/2/2009 11:34:23 PM : Outperform Start Price: $39.82 CVD Score: -1.08

Pharma outsourcing will benefit CROs in the long run.

Recs

0
Member Avatar kevinottofro (98.71) Submitted: 1/25/2009 8:56:02 AM : Outperform Start Price: $33.84 CVD Score: +23.62

Low Relative PE, good caps score, upcoming earnings not too bad decent lt growth prospects - bottom fishing.

Recs

0
Member Avatar ordinesparso (78.03) Submitted: 1/22/2009 2:49:03 PM : Outperform Start Price: $37.16 CVD Score: +7.90

10000

Recs

0
Member Avatar snooperjoe (94.20) Submitted: 12/21/2008 11:29:26 PM : Outperform Start Price: $40.87 CVD Score: +3.87

CVD is the tool that most drug companies need to employ to replenish their stable of proprietary drugs. They do not need to sell drugs, but need the demand to bring new drugs to market.

Recs

0
Member Avatar Ayax2006 (99.02) Submitted: 12/19/2008 2:02:15 AM : Outperform Start Price: $41.13 CVD Score: +3.79

contract research organization (CRO) should benefit of increasing drug tests and testing to get FDA approval.

Recs

0
Member Avatar Gumfactor (86.48) Submitted: 12/18/2008 1:56:03 PM : Outperform Start Price: $41.44 CVD Score: +3.63

Pummeled. Absolutely pummeled. From $100 to $40 this year.

But the company remains solid in every respect, and is almost guaranteed a comeback. Not to mention that the biotech sector is seeing some action as a hedge against a recession. I'm loading up on biotechs, but would probably take CVD either way.

I put it at $60 by June.

Recs

1
Member Avatar 97E3LPL (91.31) Submitted: 12/16/2008 9:12:50 AM : Outperform Start Price: $39.63 CVD Score: +6.55

Pharma is among the least affected industries, however they are seeking cost reductions, effiiciency gains, etc like everyone else. The usual and likely avenue for that is CROs, and if you read the news for this company, they are already reeping rewards.

Recs

0
Member Avatar tskephart (81.91) Submitted: 11/26/2008 12:45:58 PM : Outperform Start Price: $38.16 CVD Score: +10.35

Will benefit from pharma outsourcing

Recs

0
Member Avatar 4DJTnC (< 20) Submitted: 11/10/2008 1:21:43 PM : Outperform Start Price: $46.28 CVD Score: -7.42

FIrstly it's quite clear this one has only dropped because of the market volatility. A sector leader constantly improving on itself, as is evidenced in a number of accolades this year from its own customers. The only thumbs down below is obviously from a peta activist -- all sane writers here are thumbs up. Other than a full blown market crash, this one practically HAS to go back up. 60$ easy when the indices trend up, 80$ when recession talk dies, and 100$ a year after that.

Recs

0
Member Avatar gilboy7 (< 20) Submitted: 11/1/2008 8:10:17 PM : Outperform Start Price: $50.02 CVD Score: -10.24

way oversold

Recs

0
Member Avatar pjani06 (97.72) Submitted: 10/31/2008 8:51:15 PM : Outperform Start Price: $50.02 CVD Score: -10.24

Worldwide drug development needed - great entry point & 71-0 outperform calls by caps all stars

Recs

0
Member Avatar huskermac (61.33) Submitted: 10/28/2008 10:29:45 AM : Outperform Start Price: $44.41 CVD Score: -10.79

Victim of maket hysteria. An absolute bargain in the 40s.

Recs

0
Member Avatar tcarey2000 (31.63) Submitted: 5/19/2008 11:32:14 PM : Outperform Start Price: $82.42 CVD Score: -15.66

Rise of CROs and the Downsizi g and Globilization of Big Pharma R&D.

Results 1 - 20 of 45 1 2 3 Next »

Featured Broker Partners